AVKARE Inc. has recalled 2,135 cartons of Amantadine HCl Capsules, USP, 100 mg, which is a prescription medication (generic Symmetrel) used to treat Parkinson's disease and certain viral infections. The recall was initiated because the product failed dissolution specifications, meaning the capsules may not dissolve properly in the body to release the active medicine as intended. This specific recall affects 50-count unit dose cartons (5x10) from lot 16719 with an expiration date of 07/2018.
If the medication does not dissolve correctly, the patient may receive an inconsistent dose or an insufficient amount of the drug, which can lead to a loss of symptom control or reduced effectiveness of the treatment. No specific injuries or adverse events have been reported in the recall data.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.